(0.13%) 5 187.70 points
(0.08%) 38 884 points
(-0.10%) 16 333 points
(-0.37%) $78.09
(0.14%) $2.21
(-0.26%) $2 318.20
(-0.45%) $27.42
(-0.25%) $985.90
(0.18%) $0.931
(0.38%) $10.94
(0.19%) $0.801
(0.00%) $91.44
Quarter results tomorrow
(bmo 2024-05-09)
Expected move: +/- 0.00%
Live Chart Being Loaded With Signals
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan...
Stats | |
---|---|
Today's Volume | 13 700.00 |
Average Volume | 69 991.00 |
Market Cap | 31.95B |
EPS | ¥0 ( 2024-02-08 ) |
Next earnings date | ( ¥0 ) 2024-05-09 |
Last Dividend | ¥40.00 ( 2023-06-29 ) |
Next Dividend | ¥0 ( N/A ) |
P/E | 8.47 |
ATR14 | ¥2.38 (0.07%) |
Mizuho Medy Co.,Ltd. Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Mizuho Medy Co.,Ltd. Financials
Annual | 2023 |
Revenue: | ¥10.99B |
Gross Profit: | ¥8.03B (73.03 %) |
EPS: | ¥396.27 |
FY | 2023 |
Revenue: | ¥10.99B |
Gross Profit: | ¥8.03B (73.03 %) |
EPS: | ¥396.27 |
FY | 2022 |
Revenue: | ¥17.58B |
Gross Profit: | ¥14.10B (80.20 %) |
EPS: | ¥822.94 |
Financial Reports:
No articles found.
Mizuho Medy Co.,Ltd. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
¥0 (N/A) |
¥190.00 (N/A) |
¥0 (N/A) |
¥40.00 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
¥0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | ¥9.25 | 2015-12-28 |
Last Dividend | ¥40.00 | 2023-06-29 |
Next Dividend | ¥0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 12 | -- |
Total Paid Out | ¥555.75 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.82 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.40 | |
Div. Directional Score | 7.34 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
8035.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
7280.T | Ex Dividend Knight | 2024-03-28 | Annually | 0 | 0.00% | |
6523.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
5802.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
4544.T | Ex Dividend Junior | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
3769.T | Ex Dividend Knight | 2023-09-28 | Annually | 0 | 0.00% | |
3034.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
1914.T | Ex Dividend Junior | 2024-03-28 | Annually | 0 | 0.00% | |
9436.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% | |
8367.T | Ex Dividend Knight | 2023-09-28 | Semi-Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.343 | 1.500 | 3.13 | 4.70 | [0 - 0.5] |
returnOnAssetsTTM | 0.199 | 1.200 | 3.36 | 4.03 | [0 - 0.3] |
returnOnEquityTTM | 0.262 | 1.500 | 8.20 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0 | -1.000 | 0 | 0 | [0 - 1] |
currentRatioTTM | 7.15 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 6.38 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 3.82 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.0511 | -1.500 | 9.15 | -10.00 | [0 - 0.6] |
interestCoverageTTM | 0 | 1.000 | -1.111 | -1.111 | [3 - 30] |
operatingCashFlowPerShareTTM | 41.05 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 41.05 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.0618 | -1.500 | 9.75 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.735 | 1.000 | 1.089 | 1.089 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.469 | 1.000 | 2.62 | 2.62 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.404 | 1.000 | 8.87 | 8.87 | [0.2 - 2] |
assetTurnoverTTM | 0.580 | 0.800 | 9.47 | 7.57 | [0.5 - 2] |
Total Score | 10.28 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 8.48 | 1.000 | 9.24 | 0 | [1 - 100] |
returnOnEquityTTM | 0.262 | 2.50 | 8.84 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 41.05 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 2.38 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 41.05 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0 | 1.500 | 0 | 0 | [0 - 1] |
pegRatioTTM | 0.135 | 1.500 | -2.43 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.0356 | 1.000 | -1.611 | 0 | [0.1 - 0.5] |
Total Score | 4.40 |
Mizuho Medy Co.,Ltd.
Mizuho Medy Co.,Ltd. researches and develops, manufactures, and sells in-vitro diagnostic products and related scientific and technical information services primarily in Japan. The company provides immunoassay test products, such as influenza virus kits; RS virus and human metapneumovirus antigen test kits; streptococcus pneumoniae antigen and legionella antigen test kits; mycoplasma pneumoniae antigen test kits; adenovirus antigen test kits; rotavirus and adenovirus antigen test kits; norovirus antigen test kits; group a streptococcal antigen test kits; pregnancy test kits; ovulation test kits; and fecal occult blood test kits. It also offers gene analysis instrument; SARS-CoV-2 detection kits; and mycoplasma pneumoniae nucleic acid kits. In addition, the company engages in import and export activities. It also operates in the United States, Belgium, Finland, Netherlands, Taiwan, Thailand, etc. The company was incorporated in 1977 and is headquartered in Tosu, Japan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators